Sativex, an oral spray for people with multiple sclerosis, has been approved by the All Wales Medicines Strategy Group (AWMSG). According to the authorities, the chemical extracts of Savitex, Delta-9-tetrahydrocannabinol/cannabidiol are derived from the cannabis plant.
Story Source: The above story is based on materials provided by MEDINDIA
Note: Materials may be edited for content and length
No comments:
Post a Comment